Epidemic of metabolic diseases. A warning call;Epidemia de enfermedades metabólicas. Una llamada de atención

Medicina Clinica

Volumn 120, Issue 3, 2003, Pages 99-100

  Banegas, José R ^a   Ruilope, Luis M ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

AGE DISTRIBUTION; DYSLIPIDEMIA; EDITORIAL; EPIDEMIC; GENETIC PREDISPOSITION; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN METABOLISM; INSULIN RESISTANCE; METABOLIC DISORDER; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPIC VARIATION; PREVALENCE; SEX DIFFERENCE; SYNDROME X;

EID: 0037323693     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13042647     Document Type: Editorial

References (21)

1. Seidell JC. Obesity, insulin resistance arid diabetes -a worldwide epidemic. Br J Nutr 2000; 83(Suppl 1):S5-8.
2. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
3. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemlol 1998;148:958-66.
4. Groop L, Orho-Melander M. The dysmetabolic syndrome. J Intern Med 2001;250:105-20.
5. Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation. Diabet Med 1998;15:539-553.
6. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda: National Institutes of Health, 2001. NIH Publication 01-3670.
7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
8. Rosenbloom AL, Joe JR, Young RS, Winter NE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345-54.
9. Sinha R, Fisch G, Teague B, Tamborlane WB, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
10. Tamayo-Marco B, Faure-Nogueras E, Roche-Asensio MJ, Rubio-Calvo E. Sanchez-Oriz E, Salvador-Olivan JA. Prevalence of diabetes and impaired tolerance in Aragon, Spain. Diabetes Care 1997;20:534-6.
11. Lorenzo C, Serrano-Ríos M, Martínez-Larrad MIT, Gabriel R, Williams K, Gonzalez-Villalpando C, et al. Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study. Diabetes Care 2001;24:2059-64.
12. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Cuantificación de insulinorresistencia con los valores de insulina basal e índice HOMA en una población no diabética. Med Clin (Barc) 2001;117:530-3.
13. Morley JE. An overview of diabetes mellitus in older persons. Clin Geratr Med 1999;15:211-24.
14. Alix M. Diabetes in the elderly patient. Presse Med 2000;29:2150-55.
15. Labarthe DR. Epidemiology and prevention of cardiovascular diseases. A global challenge. Gaithersburg: Aspen Publishers, 1998.
16. Gutiérrez-Fisac JL, Banegas JR, Rodríguez-Artalejo F, Regidor E. Increasing prevalence of overweight and obesity among Spanish adults, 1987-1997. Int J Obes 2000;24:1677-82.
17. Yarbrough DE, Barrett-Connor E, Kritz-Silverstein D, Wingard DL. Birth weight, adult weight, and girth as predictors of the metabolic syndrome in posmenopausal women: the Rancho Bernardo Study. Diabetes Care 1998;21:1652-8.
18. Hales CN, Barker DJP. The thrifty phenotype hypothesis. Br Med Bull 2001;60:5-20.
19. Maison P, Byrne CD, Hales CN, Day NE, Wareham NJ. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care 2001;24:1758-63.
20. Wilson PW, Kannel WB. Obesity, diabetes, and risk of cardiovascular disease in the elderly. Am J Geriatr Cardiol 2002;11:119-23.
21. Ministerio de Sanidad y Consumo. Informe solore la salud de los Españoles: 1998. Madrid Ministerio de Sanidad y Consumo, 1999.